| Previous Close | 16.01 |
|---|---|
| Volume | 27,150 |
| Day's Range | 16.02 - 16.29 |
| 52-Week Range | 10.93 - 17.76 |
| Expense Ratio | 0.63 |
|---|---|
| Net Assets | $ 184 mil |
| Alpha | -0.02 |
| R-Squared | 0.56 |
| Dividend (Yield) | $0.00 (0.00%) |
| Avg. Market Cap | $ 7,377 mil |
| Beta | 0.84 |
| Price/Earnings | 28.43 |
| Ex-Dividend Date | NA |
| Turnover | 93.00 |
| Standard Deviation | 6.36 |
| Price/Book | 6.87 |
| Management Company | Invesco Powershares Capital Mgmt LLC |
| Administrator | Invesco Powershares Capital Mgmt LLC |
| Company of Name | % of Total | # of Shares Held |
|---|---|---|
| 1. Illumina Inc | 5.70% | 264,099 |
| 2. Waters Corp | 5.18% | 182,689 |
| 3. Sigma-Aldrich Corp | 4.98% | 181,728 |
| 4. Millipore | 4.98% | 139,381 |
| 5. Life Technologies Corp | 4.88% | 206,425 |
| 6. Gilead Sciences Inc | 4.87% | 205,741 |
| 7. Biogen Idec Inc | 4.78% | 186,452 |
| 8. Amgen | 4.78% | 156,175 |
| 9. Protalix BioTherapeutics Inc | 3.56% | 849,161 |
| 10. Nektar Therapeutics | 3.08% | 623,064 |
| % of Total Holdings | 46.79% |